128 related articles for article (PubMed ID: 18436148)
1. Cerebrovascular angiotensin AT1 receptor regulation in cerebral ischemia.
Edvinsson L
Trends Cardiovasc Med; 2008 Apr; 18(3):98-103. PubMed ID: 18436148
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
Oprisiu-Fournier R; Faure S; Mazouz H; Boutitie F; Serot JM; Achard JM; Godefroy O; Hanon O; Temmar M; Albu A; Strandgaard S; Wang J; Black SE; Fournier A
Expert Rev Neurother; 2009 Sep; 9(9):1289-305. PubMed ID: 19769445
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation.
Schulz R; Heusch G
J Hypertens Suppl; 2006 Mar; 24(1):S123-9. PubMed ID: 16601565
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure lowering in acute ischaemic stroke: an update on the role of angiotensin receptor blockers.
Sigurdsson ST; Strandgaard S
J Hypertens; 2007 Apr; 25(4):743-5. PubMed ID: 17351363
[No Abstract] [Full Text] [Related]
6. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M
J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563
[TBL] [Abstract][Full Text] [Related]
7. [Effect of angiotensin II and antagonists of the renin-angiotensin system on the cerebral circulation].
Adzhienko LM
Eksp Klin Farmakol; 2000; 63(4):74-9. PubMed ID: 11022315
[No Abstract] [Full Text] [Related]
8. Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
Mogi M; Horiuchi M
Geriatr Gerontol Int; 2013 Jan; 13(1):13-8. PubMed ID: 22726823
[TBL] [Abstract][Full Text] [Related]
9. Vascular protection in brain ischemia.
Rodríguez-Yáñez M; Castellanos M; Blanco M; Mosquera E; Castillo J
Cerebrovasc Dis; 2006; 21 Suppl 2():21-9. PubMed ID: 16651811
[TBL] [Abstract][Full Text] [Related]
10. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage.
Takizawa S; Dan T; Uesugi T; Nagata E; Takagi S; van Ypersele de Strihou C; Miyata T
J Cereb Blood Flow Metab; 2009 Oct; 29(10):1665-72. PubMed ID: 19536069
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II: multitasking in the brain.
Saavedra JM; Benicky J; Zhou J
J Hypertens Suppl; 2006 Mar; 24(1):S131-7. PubMed ID: 16601566
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin II in the response to endothelin-1 of goat cerebral arteries after ischemia-reperfusion.
Salcedo A; Fernández N; García Villalón AL; Monge L; Narváez Sánchez R; Diéguez G
Vascul Pharmacol; 2009; 50(5-6):160-5. PubMed ID: 19135174
[TBL] [Abstract][Full Text] [Related]
13. Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke.
Jackman KA; Miller AA; Drummond GR; Sobey CG
Brain Res; 2009 Aug; 1286():215-20. PubMed ID: 19559686
[TBL] [Abstract][Full Text] [Related]
14. [Antihypertensive drugs and their effects on cerebral circulation].
Nagao T; Fujishima M
Nihon Rinsho; 2000 Feb; 58 Suppl 2():237-40. PubMed ID: 11028331
[No Abstract] [Full Text] [Related]
15. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain.
Saavedra JM; Benicky J; Zhou J
Cell Mol Neurobiol; 2006; 26(7-8):1099-111. PubMed ID: 16636899
[TBL] [Abstract][Full Text] [Related]
18. [Angiotensin II-receptor antagonists compared to other antihypertensives: still insufficient evidence for reducing the risk of cerebrovascular incidents].
Meerum Terwogt JM; Koopmans RP; Roos YB; van Montfrans GA
Ned Tijdschr Geneeskd; 2008 Jan; 152(2):71-5. PubMed ID: 18265794
[TBL] [Abstract][Full Text] [Related]
19. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
[TBL] [Abstract][Full Text] [Related]
20. The effect of enalapril on skin flap viability is independent of angiotensin II AT1 receptors.
Pazoki-Toroudi H; Ajami M; Habibey R; Hajiaboli E; Firooz A
Ann Plast Surg; 2009 Jun; 62(6):699-702. PubMed ID: 19461289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
